![Factors to consider: ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]](data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7)
Recomendados
Más contenido relacionado
La actualidad más candente
La actualidad más candente (20)
Destacado
Similar a What’s New in Contraception?
Similar a What’s New in Contraception? (20)
Más de limgengyan
Más de limgengyan (20)
Último
Último (20)
What’s New in Contraception?
- 1. What’s New in Contraception? Dr Harris N. Suharjono
- 7. Advantages and Disadvantages: Ortho Evra STD protection No Weight No proven effect Periods Regulated, may be lighter and less painful Benefits Compared to OCP, maybe less effected by oral antibiotics Risks DVTs rates similar to OCP
- 11. NuvaRing Design & Composition
- 15. Advantages and Disadvantages: Nuvaring STD protection No Weight No proven effect Periods Periods do not begin while ring is inserted (only 4.4% have irregular bleeding) Benefits Easy insertion and removal, only requires action every 1-3 weeks. Reversibility 0 to 4 weeks
- 22. Advantages and Disadvantages: implanon STD protection No Weight No proven effect Periods 20% no periods, 50% with irregular periods. Benefits Rapid return to fertility, efficacy not affected by BMI, little or no risk of DVT, reduced risk of ectopic Disadvantages Menstrual irregularity, requires a minor surgical procedure, implant related problems (broken, migration, difficulty locating)
- 25. Advantages and Disadvantages: Mirena STD protection No Periods Irregularity, usually lighter. 60% have amenorrhoea by end of 1 st year Weight No proven effect Benefits Insert & forget! Excellent long term contraception plus other benefits Risks Uterine perforation (0.1%), small risk of PID and ovarian cyst (usually benign), expulsion risk(4%)
- 29. Essure:
Notas del editor
- NuvaRing is a combined contraceptive vaginal ring developed by Organon. One ring provides contraceptive protection for 1 cycle by inhibiting ovulation. The ring can be easily inserted and removed by the woman herself. After insertion, the ring should remain inserted for 3 weeks followed by a ring-free interval. The ring should always be used on the same day of the week: if it was inserted on a Wednesday, it should be removed 3 weeks later, again on a Wednesday. After the ring-free interval, a new ring should be inserted, again on a Wednesday. Once inserted, each ring releases 15 μ g EE and 120 μ g ENG per day.
- The ring is made of the plastic EVA. (Ethylene Venyl Acetate) with an outer diameter of 54 mm and a cross-sectional diameter of 4 mm. It contains ethinylestradiol (EE) and etonogestrel (ENG) uniformly dispersed in the E.V.A. core, that is surrounded by a thin outer layer that is 100% E.V.A.
- To insert NuvaRing, the woman should find a position that allows her to insert the ring easily (for instance, standing with one leg raised, squatting or lying down). The ring is then compressed between the thumb and index finger and inserted into a comfortable position in the vagina.
- For insertion, NuvaRing is compressed and inserted into the vagina. The ring should sit comfortably in the vagina; if it feels uncomfortable, it might be necessary to gently push it in a little further. The exact position of NuvaRing in the vagina is not critical for efficacy. The ring does not need to be placed around the neck of the cervix. The circular shape and flexibility of the ring allows a good fit, minimizing the risk of expulsion. The ring is easily removed by hooking the index finger around the ring or by grasping the ring between the index finger and the middle finger and just pulling it out. The used ring should be placed in the ring sachet.
- In addition to once-a-month administration, these additional aspect offer benefits to women using NuvaRing